HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lindsay, M. J. Articles by Coleman, R. E. Search for Related Content PubMed PubMed Citation Articles by Lindsay, M. J. Articles by Coleman, R. E.

The National Oncologic PET Registry: Expanded Medicare Coverage for PET Under Coverage with Evidence Development

¹ Foley Hoag, LLP, 155 Seaport Blvd., Boston, MA 02210-2600.
² Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO.
³ HealthTech, San Francisco, CA.
⁴ Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA.
⁵ Karmanos Cancer Institute, Wayne State University, Detroit, MI.
⁶ Department of Radiology, Duke University School of Medicine, Durham, NC.

Abstract

OBJECTIVE. The purpose of this article is to review the recent expansion of Medicare coverage for ¹⁸F-FDG PET for certain cancer indications under the Centers for Medicare & Medicaid Services' new Coverage with Evidence Development (CED) policy and to describe the specific operational mechanics of the National Oncologic PET Registry (NOPR).

CONCLUSION. The NOPR will make possible a more accurate assessment of the actual influence of PET on patient management across a wide spectrum of cancer indications. By linking access to PET for virtually all Medicare beneficiaries to the collection of clinically valuable evidence, the NOPR represents the cutting edge of the CED approach.

Keywords: cancer • National Oncologic PET Registry • nuclear medicine • oncologic imaging • PET • PET/CT

This article has been cited by other articles:

				B. E. Hillner, B. A. Siegel, D. Liu, A. F. Shields, I. F. Gareen, L. Hanna, S. H. Stine, and R. E. Coleman Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry J. Clin. Oncol., May 1, 2008; 26(13): 2155 - 2161. [Abstract] [Full Text] [PDF]

				B. E. Hillner, D. Liu, R. E. Coleman, A. F. Shields, I. F. Gareen, L. Hanna, S. H. Stine, and B. A. Siegel The National Oncologic PET Registry (NOPR): Design and Analysis Plan J. Nucl. Med., November 1, 2007; 48(11): 1901 - 1908. [Abstract] [Full Text] [PDF]